Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 2Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Classical hematology 1CNS 1

Conditions

Brain Neoplasms 101Glioblastoma 85Glioma 58Central Nervous System Neoplasms 34Astrocytoma 27Neuroblastoma 26Gliosarcoma 19Breast Neoplasms 19Neoplasms 18Oligodendroglioma 17Recurrence 14Neoplasm Metastasis 13Medulloblastoma 12Ependymoma 11Carcinoma, Non-Small-Cell Lung 11Lymphoma 9Sarcoma 8Osteosarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neuroma, Acoustic 7Meningioma 7Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Lung Neoplasms 7Hodgkin Disease 7Burkitt Lymphoma 7Wilms Tumor 6Sezary Syndrome 6Neuroectodermal Tumors, Primitive 6Mycosis Fungoides 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Migraine Disorders × CNS × Clear all
NCT04196933 2025-04-16

Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma

Massachusetts Eye and Ear Infirmary

Phase NA Withdrawn
CNS

Dizziness, Migraine Disorders, Motion Sickness, Neuroma, Acoustic, Vestibular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡